Bottom line
DLRHX vs SHSSX: the short answer
DLRHX (Nomura Healthcare Fund) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both mutual funds.
SHSSX is cheaper at 0.86% vs 1.46% — a difference of $60 a year per $10,000 invested.
Over five years, DLRHX returned +7.2% a year vs +5.9% for SHSSX.
Updated Nov 19, 2026
DLRHX vs SHSSX side by side
| DLRHX | SHSSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Voya | BlackRock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.46% | 0.86% |
| Annual cost per $10k | $146 | $86 |
| 10-yr cost on $10k (prospectus) | $1,797 | $1,061 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +21.8% | +16.3% |
| 5-yr return (annualized) | +7.2% | +5.9% |
| 10-yr return (annualized) | +9.9% | +9.8% |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $750.2M | $5.9B |
| Number of holdings | 108 | 155 |
| Portfolio turnover | 4% | 49% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
12 of DLRHX's top 25 holdings also appear in SHSSX's top 25.
| Holding | DLRHX | SHSSX |
|---|---|---|
| Abbvie Inc | 4.19% | 3.94% |
| Eli Lilly & Company | 4.16% | 12.29% |
| Regeneron Pharmaceuticals Inc | 3.91% | 0.91% |
| Unitedhealth Group Inc | 3.88% | 6.10% |
| Pfizer Inc | 3.84% | 2.61% |
| Merck & Company Inc | 3.68% | 4.94% |
| Gilead Sciences Inc | 3.54% | 4.19% |
| Astrazeneca Plc | 3.27% | 1.21% |
| Elevance Health Inc | 3.25% | 1.56% |
| Amgen Inc | 2.27% | 3.37% |
| Vertex Pharmaceuticals Inc | 1.66% | 2.74% |
| Boston Scientific Corp | 1.42% | 1.59% |
Source: SEC Form N-PORT
DLRHX top 10
- Ucb Sa — 5.19%
- Abbvie Inc — 4.19%
- Eli Lilly & Company — 4.16%
- Regeneron Pharmaceuticals Inc — 3.91%
- Unitedhealth Group Inc — 3.88%
- Pfizer Inc — 3.84%
- Merck & Company Inc — 3.68%
- Gilead Sciences Inc — 3.54%
- Astrazeneca Plc — 3.27%
- Elevance Health Inc — 3.25%
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
FAQ
What is the difference between DLRHX and SHSSX?
DLRHX (Nomura Healthcare Fund) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both mutual funds. SHSSX is cheaper at 0.86% vs 1.46% — a difference of $60 a year per $10,000 invested.
Which is cheaper, DLRHX or SHSSX?
SHSSX has the lower expense ratio (0.86%).
Should I own both DLRHX and SHSSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.